AgeX Therapeutics, Inc. (AGE)
NYSEAMERICAN: AGE · IEX Real-Time Price · USD
0.786
-0.014 (-1.79%)
Jan 27, 2023, 4:00 PM EST - Market closed
Cash Flow Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Net Income
|
-8.68 | -10.87 | -12.15 | -7.5 | -6.58 | -15.49 |
| Depreciation & Amortization
|
0.13 | 1.26 | 0.95 | 0.54 | 0.68 | 0.85 |
| Share-Based Compensation
|
1 | 0.91 | 1.91 | 1.29 | 0.34 | 0.98 |
| Other Operating Activities
|
-0.31 | 0.88 | -0.86 | -2.32 | -0.73 | 5.24 |
| Operating Cash Flow
|
-7.86 | -7.82 | -10.16 | -8 | -6.29 | -8.43 |
| Capital Expenditures
|
0 | -0.02 | -0.64 | -0.02 | -0 | -0.02 |
| Acquisitions
|
0.42 | 0 | 0 | 0 | -0 | 0 |
| Change in Investments
|
0.25 | 0 | 0.35 | 3.22 | 0 | 0 |
| Other Investing Activities
|
- | - | -0.07 | -1.87 | 0.01 | -0.01 |
| Investing Cash Flow
|
0.67 | -0.02 | -0.36 | 1.33 | 0.01 | -0.03 |
| Share Issuance / Repurchase
|
0.5 | 0 | 4.5 | 6 | 10 | 0 |
| Debt Issued / Paid
|
6.75 | 6.12 | 1.77 | 0 | 0 | 0 |
| Other Financing Activities
|
- | -0.16 | - | - | 3.28 | 7.25 |
| Financing Cash Flow
|
7.25 | 5.96 | 6.27 | 6 | 13.28 | 7.25 |
| Net Cash Flow
|
0.06 | -1.88 | -4.26 | -0.67 | 7.12 | -1.24 |
| Free Cash Flow
|
-7.86 | -7.84 | -10.8 | -8.02 | -6.29 | -8.45 |
| Free Cash Flow Margin
|
-5454.86% | -2170.91% | -625.06% | -574.21% | -447.72% | -507.20% |
| Free Cash Flow Per Share
|
-0.21 | -0.21 | -0.29 | -0.23 | -0.20 | -0.29 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).